Gilead Sciences, Inc.
GILD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $6 | $5 | $5 |
| Short-Term Investments | $2 | $1 | $1 | $1 |
| Receivables | $4 | $5 | $5 | $4 |
| Inventory | $2 | $2 | $2 | $2 |
| Other Curr. Assets | $1 | $2 | $2 | $2 |
| Total Curr. Assets | $19 | $16 | $14 | $15 |
| Property Plant & Equip (Net) | $5 | $5 | $5 | $5 |
| Goodwill | $8 | $8 | $8 | $8 |
| Intangibles | $20 | $26 | $29 | $33 |
| Long-Term Investments | $0 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $5 | $5 | $5 |
| Total NC Assets | $40 | $46 | $49 | $53 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $59 | $62 | $63 | $68 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $1 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $8 | $7 | $9 |
| Total Curr. Liab. | $12 | $11 | $11 | $12 |
| LT Debt | $25 | $23 | $23 | $25 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $2 | $3 | $4 |
| Other NC Liab. | $2 | $3 | $5 | $6 |
| Total NC Liab. | $28 | $28 | $31 | $35 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $40 | $39 | $42 | $47 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $11 | $16 | $16 | $16 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $8 | $7 | $6 | $5 |
| Total Equity | $19 | $23 | $21 | $21 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $59 | $62 | $63 | $68 |
| Net Debt | $17 | $19 | $20 | $21 |